Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
65.99B | 61.84B | 54.61B | 44.61B | 38.25B | 43.44B | Gross Profit |
39.48B | 36.40B | 31.06B | 25.65B | 22.63B | 25.73B | EBIT |
6.63B | 4.92B | 1.74B | 265.25M | -452.90M | 1.97B | EBITDA |
8.42B | 6.87B | 3.66B | 3.70B | 1.41B | 3.30B | Net Income Common Stockholders |
4.40B | 3.26B | 1.01B | 1.30B | -443.06M | 292.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.55B | 10.55B | 7.69B | 7.00B | 5.26B | 3.47B | Total Assets |
32.92B | 32.77B | 30.76B | 26.91B | 23.94B | 20.48B | Total Debt |
10.12B | 10.12B | 12.38B | 11.15B | 10.36B | 6.64B | Net Debt |
-428.23M | -428.23M | 4.69B | 4.16B | 5.10B | 3.17B | Total Liabilities |
19.38B | 19.24B | 20.46B | 17.61B | 15.85B | 11.91B | Stockholders Equity |
13.54B | 13.54B | 10.30B | 9.30B | 8.10B | 8.57B |
Cash Flow | Free Cash Flow | ||||
4.59B | 5.09B | 2.67B | 2.59B | 45.12M | 1.80B | Operating Cash Flow |
6.49B | 6.22B | 4.68B | 4.03B | 1.60B | 3.03B | Investing Cash Flow |
-1.82B | -906.26M | -2.19B | -1.85B | -2.08B | -1.55B | Financing Cash Flow |
-3.63B | -2.60B | -1.86B | -509.25M | 2.22B | -2.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥68.98B | 13.87 | 1.80% | 9.11% | 52.03% | ||
71 Outperform | ¥65.84B | 20.80 | 1.92% | 0.46% | 626.15% | ||
68 Neutral | ¥126.50B | 43.97 | 1.25% | 9.79% | 4.81% | ||
66 Neutral | ¥113.01B | 35.90 | 0.82% | 3.36% | 22.37% | ||
65 Neutral | ¥57.38B | 59.85 | 0.53% | 8.92% | 28.78% | ||
63 Neutral | ¥73.27B | 71.01 | 0.34% | 1.40% | -26.08% | ||
62 Neutral | $6.90B | 11.12 | 2.92% | 3.89% | 2.68% | -25.06% |